Cannabinoid treatment showed an overall trend toward reduced GPR55 expression, except for ps318 administered as monotherapy or in combination with OEA.
← all excerpts
Acute Effects of Cannabinoid Combination Therapies in a Western Diet-Induced Murine Model of Metabolic Liver Disease.
2
—
—
The sentences
Similarly, monotherapy treatment of CBD (16.33 ± 4.36 U/L), OEA (59.11 ± 19.93 U/L), and compound ps318 (31.24 ± 4.36 U/L) showed a trend toward reducing ALT levels in plasma.